1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc.
XNAS: NBIX
Await Turnaround
Download real time
131.75 0.08 (0.06%)
381.4K
XNAS Volume

XNAS 01 May, 2026 3:46 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Neurocrine Biosciences Inc is on 05 May 2026 for the purpose of Neurocrine Biosciences Inc First Quarter Earnings Results for 2026 See details

Neurocrine Biosciences Inc - NBIX - stock price prediction, stock price target, analyst ratings from 27 analysts

Neurocrine Biosciences Inc has a share price target of US$ 186, revenue growth forecast of 27.8%, and profit growth estimate of -2.9% for FY26, based on top 27 analyst calls.

Forecaster Screeners